RTW Investments, LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
RTW Investments, LP disclosed 68 US equity positions worth $6.9bn in its Q3 2024 13F filing. The largest position was MDGL at 6.1% of the reported book, followed by AXSM and RNAGBP.
What did RTW Investments, LP own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 6.1% | $423.1m | 1,993,687 | – | |
| 2 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 5.4% | $376.5m | 4,189,557 | – | |
| 3 | RNAGBP AVIDITY BIOSCIENCES INC | 5.4% | $373.5m | 8,132,870 | – | ||
| 4 | ARGX ARGENX SE | Healthcare | 5.1% | $354.8m | 654,430 | – | |
| 5 | NTRA NATERA INC | Healthcare | 4.8% | $329.2m | 2,593,323 | – | |
| 6 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 4.7% | $326.7m | 17,687,772 | – | |
| 7 | PTCT PTC THERAPEUTICS INC | Healthcare | 4.0% | $274.3m | 7,393,127 | – | |
| 8 | DYN DYNE THERAPEUTICS INC | Healthcare | 3.5% | $244.9m | 6,818,641 | – | |
| 9 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 3.5% | $244.2m | 5,426,112 | – | |
| 10 | BRKR BRUKER CORP | Healthcare | 3.5% | $240.4m | 3,481,119 | – | |
| 11 | INSM INSMED INC | Healthcare | 3.5% | $238.9m | 3,272,008 | – | |
| 12 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 3.1% | $210.8m | 13,707,506 | – | |
| 13 | MERUS N V | 3.0% | $208.3m | 4,169,393 | – | ||
| 14 | GERN GERON CORP | Healthcare | 2.9% | $200.3m | 44,111,916 | – | |
| 15 | MASI* MASIMO CORP | 2.8% | $195.0m | 1,462,400 | – | ||
| 16 | ALKS ALKERMES PLC | Healthcare | 2.7% | $186.2m | 6,654,033 | – | |
| 17 | AKERO THERAPEUTICS INC | 2.5% | $169.8m | 5,919,435 | – | ||
| 18 | APGE APOGEE THERAPEUTICS INC | Healthcare | 2.3% | $159.3m | 2,712,096 | – | |
| 19 | PEN PENUMBRA INC | Healthcare | 2.2% | $154.6m | 795,750 | – | |
| 20 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 2.2% | $151.6m | 4,869,798 | – | |
| 21 | CYTK CYTOKINETICS INC | Healthcare | 2.1% | $143.7m | 2,721,158 | – | |
| 22 | SYK STRYKER CORPORATION | Healthcare | 2.1% | $143.4m | 396,921 | – | |
| 23 | RDNT RADNET INC | Healthcare | 1.8% | $125.5m | 1,808,604 | – | |
| 24 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 1.7% | $114.5m | 2,645,703 | – | |
| 25 | IMTX IMMATICS N.V | Healthcare | 1.7% | $114.1m | 10,000,000 | – | |
| 26 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 1.6% | $112.2m | 3,412,486 | – | |
| 27 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.6% | $109.3m | 1,968,002 | – | |
| 28 | SYRE SPYRE THERAPEUTICS INC | 1.4% | $95.8m | 3,258,360 | – | ||
| 29 | CRGX CARGO THERAPEUTICS INC | 1.1% | $75.6m | 4,098,955 | – | ||
| 30 | ARVN ARVINAS INC | Healthcare | 1.0% | $68.5m | 2,782,329 | – | |
| 31 | STOK STOKE THERAPEUTICS INC | Healthcare | 0.8% | $57.2m | 4,652,285 | – | |
| 32 | ETNBGBP 89BIO INC | 0.8% | $54.6m | 7,378,548 | – | ||
| 33 | CGON CG ONCOLOGY INC | Healthcare | 0.7% | $50.7m | 1,344,074 | – | |
| 34 | GKOS GLAUKOS CORP | Healthcare | 0.7% | $50.3m | 386,291 | – | |
| 35 | URGN UROGEN PHARMA LTD | Healthcare | 0.7% | $48.1m | 3,787,347 | – | |
| 36 | NGNE NEUROGENE INC | 0.7% | $47.6m | 1,135,256 | – | ||
| 37 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.7% | $45.4m | 1,850,648 | – | |
| 38 | OBIO ORCHESTRA BIOMED HLDGS INC | 0.6% | $42.2m | 8,206,159 | – | ||
| 39 | SG7 SAGE THERAPEUTICS INC | 0.6% | $40.4m | 5,591,700 | – | ||
| 40 | TSHA TAYSHA GENE THERAPIES INC | Healthcare | 0.4% | $30.0m | 14,946,420 | – | |
| 41 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.4% | $28.6m | 1,705,960 | – | |
| 42 | TEM TEMPUS AI INC | Healthcare | 0.3% | $22.6m | 400,000 | – | |
| 43 | GHRS GH RESEARCH PLC | 0.3% | $22.3m | 3,327,129 | – | ||
| 44 | LENZ LENZ THERAPEUTICS INC | Healthcare | 0.3% | $20.5m | 863,389 | – | |
| 45 | EPIEUR ESSA PHARMA INC | 0.3% | $19.8m | 3,261,496 | – | ||
| 46 | TRML TOURMALINE BIO INC | 0.3% | $19.1m | 741,656 | – | ||
| 47 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 0.3% | $18.3m | 666,667 | – | |
| 48 | ROIV ROIVANT SCIENCES LTD | Healthcare | 0.2% | $16.8m | 1,454,273 | – | |
| 49 | BIOA BIOAGE LABS INC | 0.2% | $16.4m | 786,353 | – | ||
| 50 | REPL REPLIMUNE GROUP INC | Healthcare | 0.2% | $12.4m | 1,133,787 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.